研究実績  |  RESULTS ACHIEVEMENT

学会発表(海外)

    2019
  • Kawasaki T, Ueda S, Ichinose Y, Hirokawa E, Shimada H, Sugitani I, Sano H, Hasebe T, Takahashi T, Osaki A, Saeki T, Oikawa Y, Inoue I, Noda M, Shimada A, Nagashima Y, Kamada K, Kanno S, Urano M, Kuroda M, Utsumi T, Hayashi T. High-molecular-weight insulin-like growth factor 2 secreting phyllodes tumor of the breast presenting as a hypoglycemic attack. 31st European Congress of Pathology, Nice, France, 2019

  • 2019
  • Shimada A, Satomura A, Haisa A, Oikawa Y. Significance of anti-insulin immune responses in autoimmune diabees with HLA DR9. 79th American Diabetes Association Scientific Sessions, San Francisco, California, USA, 2019

  • 2019
  • Oikawa Y, Kondo T, Shimada A, Seino Y, Kitaoka M. A considerable mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody. 79th American Diabetes Association Scientific Sessions, San Francisco, California, USA, 2019

  • 2018
  • Shimada A. Type 1 diabetes–pathophysiology and diagnosis. 18th annual ISPAD Science School for Physicians. Shonan Village Center, Kanagawa, Japan, 2018
  • 2018
  • Oikawa Y, katsuki T, Kawai T, Shimada A. A cut-off value for anti-GAD antibody ELISA test for predicting future insulin dependency in SPIDDM may not exist. 78th American Diabetes Association Scientific Sessions, Orlando, Florida, USA, 2018
  • 2017
  • Noda M. The Japanese experience (in symposium “East-West Forum: diabetes outcome trends”). 53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon, Portugal, 2017
  • 2017
  • Noda M. Clinical practice guideline for the treatment of diabetes in Japan – concept and essence (in symposium “International clinical practice guidelines for diabetes mellitus; NICE, IDF, AACE, JDS, and KDA”). 2017 International Congress of Diabetes & Metabolism, Seoul, Korea, 2017
  • 2017
  • Oikawa Y, Yajima K, Hashiguchi A, Shimada A. Immunological Significance of CD4+ T-Cells in Acute-Onset Type 1 Diabetes Characterized by CD4+ T Cells-Dominant Insulitis. 77th American Diabetes Association Scientific Sessions, San Diego, California, USA, 2017
  • 2017
  • Shimada A, Satomura A, Miyashita Y, Oikawa Y, Inoue I, Noda M. Insulin Peptide Reactive T-Cells Detected in Ketosis-Prone Type 2 Diabetes. 77th American Diabetes Association Scientific Sessions, San Diego, California, USA, 2017
  • 2016
  • Hatano M. Prevalence of Hypertension in Japanese Diebetes Mellitus with Pre‐Hypertension and Normotension. 4th International Conference on PreHypertension, Hypertension and Cardio Metabolic Syndrome. Venice, Italy, 2016
  • 2016
  • Kabeya Y, Uchida J, Oikawa Y, Shimada A, Atsumi Y. Factors Affecting Length of Consultation Time in Diabetes Practice. 76th American Diabetes Association Scientific Sessions, New Orleans, Louisiana, USA, 2016
  • 2016
  • Oikawa Y, Matsushita M, James EA, Hattori Y, Shimada A. GAD-related Peptide-specific CD4 T Cells Were Detected in Patients with Type 1 Diabetes with HLA-DRB1*09:01. 76th American Diabetes Association Scientific Sessions, New Orleans, Louisiana, USA, 2016
  • 2016
  • Shimada A, Oikawa Y, Matsushita M, Hattori Y. Serum CXCL10 Reflects Insulin-specific T Cell Response in Type 1 Diabetes. 76th American Diabetes Association Scientific Sessions, New Orleans, Louisiana, USA, 2016

ACCESSご案内

埼玉医科大学

埼玉医科大学病院

〒350-0495 埼玉県入間郡毛呂山町毛呂本郷38
TEL: 049-276-1204
FAX: 049-294-9752

お車をご利用される方
鶴ヶ島インターから約10km(約20~30分)
詳しくはこちら

電車・バスをご利用される方
池袋駅より東毛呂駅まで約1時間
東毛呂駅からバス(約5分)もしくは徒歩(約20分)
詳しくはこちら

本フォームは医療従事者専用となっております。ご病状やお薬、検査、予約など診療に関する患者さんからのご相談は、法律上、一切お受けすることができません。ご理解のほどよろしくお願いいたします。